Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
RegistrantPHARMA TO MARKET PTE. LTD.
Product Classification
D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification
Formulation Information
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
INTRAVENOUS
Medical Information
L01XC03
xl 01 xc 03
Manufacturer Information
PHARMA TO MARKET PTE. LTD.
Biocon Biologics India Limited (Powder & Solvent)
Active Ingredients
Documents
Package Inserts
CANHERA PI.pdf
Approved: November 25, 2021